Acute renal failure in hematopoietic cell transplantation

Kidney International

Volumn 69, Issue 3, 2006, Pages 430-435

  Parikh, C R ^a   Coca, S G ^b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic; Autologous; Chronic kidney disease; Hepatic veno occlusive disease; Non myeloablative allogeneic; Thrombotic microangiopathy

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; METHOTREXATE; STEROID; TACROLIMUS;

ACUTE KIDNEY FAILURE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; KIDNEY FAILURE; LIVER VEIN OBSTRUCTION; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MYELOABLATIVE CONDITIONING; ORGAN DONOR; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEPSIS; SHORT SURVEY; SURVIVAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; TUMOR LYSIS SYNDROME;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RISK FACTORS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 31544461541     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000055     Document Type: Short Survey

References (20)

1. Zager RA, O'Quigley J, Zager BK et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 1989; 13: 210-216.
2. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994; 46: 1443-1458.
3. Gruss E, Bernis C, Tomas JF et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol 1995; 15: 473-479.
4. Nash RA, Antin JH, Karanes C et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062-2068.
5. Parikh CR, McSweeney PA, Korular D et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 2002; 62: 566-573.
6. Parikh CR, Schrier RW, Storer B et al. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 2005; 45: 502-509.
7. Parikh CR, Sandmaier BM, Storb RF et al. Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol 2004; 15: 1868-1876.
8. Merouani A, Shpall EJ, Jones RB et al. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int 1996; 50: 1026-1031.
9. Fadia A, Casserly LF, Sanchorawala V et al. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int 2003; 63: 1868-1873.
10. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
11. Roy V, Rizvi MA, Vesely SK et al. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 2001; 27: 641-646.
12. Hingorani SR, Guthrie K, Batchelder A et al. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int 2005; 67: 272-277.
13. Rao PS. Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis 2005; 45: 780-785.
14. Panoskaltsis-Mortari A, Price A, Hermanson JR et al. In vivo imaging of graft-versus-host-disease in mice. Blood 2004; 103: 3590-3598.
15. Oliver JA, Maarouf O, Cheema FH et al. The renal papilla is a niche for adult kidney stem cells. J Clin Invest 2004; 114: 795-804.
16. Krause D, Cantley LG. Bone marrow plasticity revisited: protection or differentiation in the kidney tubule? J Clin Invest 2005; 115: 1705-1708.
17. Parikh CR, McSweeney P, Schrier RW. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 2005; 67: 1999-2005.
18. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 1549-1558.
19. Cohen EP. Radiation nephropathy after bone marrow transplantation. Kidney Int 2000; 58: 903-918.
20. Weiss A, Sandmaier BM, Storer B et al. Chronic kidney disease following nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 2006; 6: 89-94.